…And a Penny Earned

Baxter saw its earnings rise by 19% to 44 US cents a share, up from 37 US cents a share at the same stage a year earlier.

Read the full article » | Posted 02-08-2017

Related Articles

• Nephrologist Dr. Roberto Collazo Shares New Treatments for Kidney Disease and ESKD Posted 12-11-2024
• Ellen Lukens from CMMI Presents on the Kidney Care Choices Model Posted 12-11-2024
• 2025 NKF Survey on Kidney Health Priorities Finds Home Dialysis is a Patient Priority Posted 12-11-2024
• FDA Correction on Baxter MiniCap Extended Life PD Transfer Set Posted 12-11-2024